Skip to content

XVIVO Organ Chamber™ 19020Recalls & reported problems

Xvivo Perfusion AB · The XVIVO Organ Chamber™ is intended to be used as a temporary receptacle for isolated donor lungs in preparation for eventual transplantation into a recipient. · Class 3

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07350069520074), received between Apr 19, 2022 and Apr 19, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Unsealed Device Packaging” (1 report).

1 FDA recall record name this device's identifier.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Apr 8, 2022Class IITerminated

    The weld seal of the primary pouch was incomplete, and the sterility of the product cannot be ensured/guaranteed.

    Z-1212-2022 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • Unsealed Device Packaging1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 19, 2022Unsealed Device Packaging; Unsealed Device Packaging

    MALFUNCTION ACCORDING TO THE REPORTER THREE DEVICES WITH UNSEALED STERILE BARRIER WERE FOUND AT USER FACILITY QUALITY INSPECTION WHEN RECEIVING THE GOODS.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14140108 ↗

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page